NASDAQ · Medical - Devices

HSDT (HSDT) Stock

$1.69 +0.60% NASDAQ: HSDT Healthcare

Valuation

MetricValue
Price$1.69
Market Cap$98.67M
P/E Ratio-1.25
P/B Ratio0.45
P/S Ratio14.07
EPS (TTM)$-1.85
52-Week High$25.50
52-Week Low$1.19
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-13.62%
ROA-13.49%
ROCE-6.98%
Gross Margin-350.00%
Operating Margin-350.00%
Net Margin-14.27%
Debt/Equity0.00
Current Ratio10.33

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$1.0M$1.0M$1.0M$6.0M
Operating Profit$-18.0M$-16.0M$-12.0M$-14.0M$-21.0M
Net Profit$-18.0M$-14.0M$-9.0M$-12.0M$-41.0M
EPS$-184.51$-26.06$-7.28$-4.33$-1.85
Op Margin-3475.5%-1971.5%-1929.8%-2673.7%-351.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$14.0M$17.0M$8.0M$4.0M$304.0M
Total Liabilities$3.0M$9.0M$5.0M$2.0M$3.0M
Cash$11.0M$15.0M$5.0M$1.0M$7.0M
Borrowings$0$0$0$0$0

Latest News

Solana Company Partners With Alatau City to Advance Central Asia Blockchain Push CryptoProwl · Jun 30, 2026 Solana to Establish Blockchain Partnership With Kazakhstan's Alatau City MT Newswires · Jun 30, 2026 Solana (NasdaqCM:HSDT) Stock Fair Value Moves Lower As Analysts Trim Growth Outlook Simply Wall St. · Jun 27, 2026 Ethereum Foundation Cuts Another 40% But Solana Founder Calls It Bullish BeInCrypto · Jun 23, 2026 Solana Company Rejects Unsolicited Acquisition Offer From Forward Industries MT Newswires · Jun 16, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-13.0M$-14.0M$-10.0M$-11.0M$-17.0M
Investing Cash Flow$0$0$0$0$-471.0M
Financing Cash Flow$0$0$0$4.0M$-17.0M
Net Cash Flow$8.0M$4.0M$-9.0M$-4.0M$6.0M
Free Cash Flow$-13.0M$-14.0M$-10.0M$-11.0M$-61.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-13.20%
Quick Ratio9.90
Interest Coverage-21.00
Return 1Y-76.78%
Return 3Y-99.97%
Return 5Y-100.00%

Ownership

Insiders Held22.26%
Institutions Held28.21%
Institutions Float Held36.29%
Institutional HolderSharesReport Date
Kathmere Capital Management, Llc4,594,9602026-03-31
Pantera Capital Partners LP3,887,3192026-03-31
Yorkville Advisors Global, LP1,085,0002026-03-31
Arrington Capital Management, LLC658,9082026-03-31
Vr Advisory Services Ltd581,3102026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CATX $3.00 +1.01% -2.59 $342.14M 0.00%
ELMD $39.48 -0.95% 32.25 $326.90M 0.00%
INFU $9.92 +5.98% 32.90 $200.20M 0.00%
INGN $6.49 +1.09% -8.00 $175.71M 0.00%
NNOX $1.06 +3.92% -1.56 $73.78M 0.00%

About HSDT

HSDT is led by CEO Dane Carl Andreeff, employs 21 people, headquartered in US, publicly traded since 2014.

HSDT stock trades at $1.69 with a market capitalization of $98.67M. The stock is valued at a price-to-earnings (P/E) ratio of -1.25, price-to-book of 0.45, price-to-sales of 14.07. Over the past 52 weeks the stock has ranged between $1.19 and $25.50, and currently trades 93.4% below its 52-week high.

On profitability, HSDT generates a return on equity (ROE) of -13.62%, return on capital employed of -6.98%, an operating margin of -350.00%, a net profit margin of -14.27%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides